The global facility management market is anticipated to grow at a considerable CAGR of 13.5% during the forecast period (2022-2028). The speeding up in the adoption of cloud-based solutions is one of the prime factors affecting and driving the market. Cloud-based facility management software supports in conveniently accessing it from anywhere and at any time, as it significantly improves employee productivity and collaboration. This also supports decreasing the operating costs of organizations as the software enhances better and more effective security, scalability, along with quick disaster recovery. 

The global eosinophilic esophagitis treatment market is anticipated to grow at a considerable CAGR of 6.4% during the forecast period (2022-2028). The Increasing prevalence of eosinophilic esophagitis across the globe is one of the prime factors affecting and driving the market for eosinophilic esophagitis treatment. According to the information by the National Institutes of Health (NIH), the Eosinophilic esophagitis incidence increased from 0.01 % in 1995 to 3.16 % per 100.000 inhabitants in 2019. 

The global dental bone graft substitutes market is anticipated to grow at a considerable CAGR of 7.2% during the forecast period (2022-2028). The growing aging population is one of the prime factors that has been contributing to the market growth. As per the information of the United Nations (UN), which highlighted the fact that the aged population, or people above the age of 60, by 2050 is anticipated to double. As, older adults often have a problem related to receding gums, cavities that are probably to evolve at the root of the tooth. Through this increasing population of aged people, dental surgeries are supposed to be generated more in numbers which is enhancing the growth of the market.

The global rare neurodegenerative disease treatment market is anticipated to grow at a considerable CAGR of 68% during the forecast period (2022-2028). All the market players of drug manufacturing company are involved in strategic alliances like acquisitions, partnership and collaboration along with research and development to launch new products to hold their position in the global market. Recently, EPSEN Pharma and Exicure Inc. have signed an exclusive agreement to research, develop and commercialize Spherical Nucleic acid as potential investigation treatment for neurodegenerative disease.

The global inhalation and nasal spray generic drugs market is anticipated to grow at a significant CAGR of around 7.9% during the forecast years. The generic drugs mainly are sold by their chemical name and cost less than any other branded drugs. One of the key factors driving the growth of the market is changes in the environment due to which people are facing allergic problems including runny, stuffy nose, watery eyes, couching, problems in breathing, and many others. The use of inhalation and nasal spray is the most common treatment for these allergic problems. Furthermore, the increasing number of asthma patients has also increased the demand for inhalation and nasal sprays.

The global methylmalonic acid market is anticipated to grow at a significant CAGR of 4.5% during the forecast period (2022-2028). The growing awareness amongst people towards health consciousness has significantly helped in boosting the global methylmalonic acid market. The methylmalonic acid blood test is used to diagnose the deficiency of vitamin B12 in the human body. The test is also used to diagnose methylmalonic acidemia (MMA), a rare genetic disorder disease. Product innovations coupled up with many leading advancements and research pipelines in the methylmalonic acid market are anticipated to drive the market in the coming years. 

The global flexible spinal implants market is anticipated to grow at a CAGR of around 4.8% during the forecast period. The usage of spinal implants during spine fusion surgery in combination with bone graft contributes to the growth of the spinal implants market. The increase in the number of spine fusion surgery with use of instruments including plates, screws, rods, and cages has also increased the demand for spinal implants. 

The global bisacodyl market is anticipated to grow at a considerable CAGR of 5.9 % during the forecast period (2022- 2028). Innovations coupled up with many leading technological advancements and key acquisitions are anticipated to drive the global bisacodyl over the forecast period. The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansions, and product innovations to remain competitive in the market.

The global weight reduction medicine market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). The major driving factor for the growth of the weight reduction medicine market is unhealthy lifestyle and stress among population globally. People with busy lifestyles do not spare time to have a scheduled exercise routine each day. This is causing a negative impact on their body. Alcohol consumption has also proved to be a reason for an increase in weight. Pharmaceutical companies  are including herbal plants and natural weight loss supplements to foster a safe, healthy weight loss regime in the consumers. 

The global thymopentin market is anticipated to grow at a significant CAGR during the forecast period. With a short plasma half-life (the 30s) and a long treatment time, thymopentin (TP5) is extensively utilized in the treatment of autoimmune illnesses (7 days to 6 months). It's commonly given via syringe injection, that leads to poor patient compliance. Due to it facilitating painless penetration through the stratum corneum and generating less biohazardous waste after dissolving in the skin, the dissolving microneedle array (DMNA) is a superior technique for transdermal administration of biological macromolecules. Despite recent developments in DMNA as a unique technique for transdermal drug administration, the problem of mechanical weakness remains unsolved. A modified two-step molding process was used to manufacture TP5-loaded DMNA (TP5-DMNA) in this study.